Tanvex BioPharma, Inc. (TPE:6541)
Taiwan
· Delayed Price · Currency is TWD 47.45
-1.15 (-2.37%)
Mar 3, 2026, 1:07 PM CST
-39.17% (1Y)
| Market Cap | 12.87B |
| Revenue (ttm) | 224.83M |
| Net Income (ttm) | -1.36B |
| Shares Out | 264.82M |
| EPS (ttm) | -6.18 |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 539,297 |
| Average Volume | 783,136 |
| Open | 48.60 |
| Previous Close | 48.60 |
| Day's Range | 47.40 - 48.60 |
| 52-Week Range | 47.40 - 79.30 |
| Beta | -0.02 |
| RSI | 39.81 |
| Earnings Date | Mar 12, 2026 |